| Literature DB >> 33492499 |
José Daniel Marroquín-Reyes1, Sergio Zepeda-Gómez2, Alejandra Tepox-Padrón1, Mariana Quintanar-Martínez1, Omar Edel Trujillo-Benavides3, Félix I Téllez-Avila4.
Abstract
BACKGROUND: During the COVID-19 pandemic, several questions have arisen about which endoscopic procedures (EPs) must be performed and which ones can be postponed. The aim of this study was to conduct a nationwide survey regarding the appropriate timing of EPs during the COVID-19 pandemic.Entities:
Keywords: COVID-19; Endoscopic procedures; Pandemic
Mesh:
Year: 2021 PMID: 33492499 PMCID: PMC7831145 DOI: 10.1007/s00464-021-08290-8
Source DB: PubMed Journal: Surg Endosc ISSN: 0930-2794 Impact factor: 3.453
Fig. 1In which one do you consider that postponing EP > 8 weeks can lead to disease progression that puts the patients at risk or an increase in the severity of symptoms? EP endoscopic procedure; EU endoscopic ultrasound; BD bile duct; SBB small bowel bleeding; HGD high grade dysplasia
Fig. 2In which one do you think it is possible to postpone EP > 8 weeks without a negative impact on the patient's health. EP endoscopic procedure; LGIB lower gastrointestinal bleeding; VA villous adenoma; FIT faecal immunochemical test; IM intestinal metaplasia
Time when endoscopic evaluation is considered necessary for different clinical scenarios (n = 214)
| Scenario | 1 month | 1–2 months | 2–3 months | > 3 months |
|---|---|---|---|---|
| Iron deficiency anaemia without overt bleeding | 59 (27.2) | 77 (36.4) | 42 (19.7) | 36 (16.6) |
| Refractory GERD without alarm features | 15 (7.2) | 54 (25.1) | 63 (29.5) | 82 (38.0) |
| EV ligation for eradication protocol | 42 (19.7) | 87 (40.8) | 49 (22.8) | 36 (16.6) |
| Asymptomatic biliary stricture | 101 (47.4) | 62 (28.7) | 35 (16.4) | 16 (7.4) |
| Non-urgent BS replacement | – | – | 129 (59.7) | 85 (39.5) |
| Granular LECL resection without suspected carcinoma | 29 (13.8) | 100 (46.7) | – | 85 (39.5) |
| Dyspepsia with alarm features | 142 (65.8) | 33 (15.6) | 23 (10.8) | 16 (7.7) |
| Incidental GI tract tumour in imaging studies | 165 (77.2) | – | 45 (20. 6) | 4 (2.1) |
| Ampuloma | 118 (55.0) | 56 (26.4) | 32 (14.6) | 8 (3.8) |
| Dysphagia with alarm features | 205 (95.9) | 8 (3.7) | – | 1 (0.3) |
GERD gastroesophageal reflux disease; EV oesophageal varices; BS biliary stent; LECL laterally extended colonic lesion; GI gastrointestinal